Guardant Health
GH
#1514
Rank
C$18.94 B
Marketcap
C$145.87
Share price
3.45%
Change (1 day)
183.48%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2025 : C$1.76 Billion

According to Guardant Health 's latest financial reports the company's total assets are C$1.76 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$2.13 B-10.03%
2023-12-31C$2.36 B8.46%
2022-12-31C$2.18 B-22.24%
2021-12-31C$2.80 B-3.01%
2020-12-31C$2.89 B130.42%
2019-12-31C$1.25 B57.11%
2018-12-31C$0.80 B85.58%
2017-12-31C$0.43 B175.24%
2016-12-31C$0.15 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Natera
NTRA
C$2.51 B 42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
C$4.66 B 164.58%๐Ÿ‡บ๐Ÿ‡ธ USA